Oregon Pacific Wealth Management LLC Invests $424,000 in UnitedHealth Group Incorporated (NYSE:UNH)

Oregon Pacific Wealth Management LLC bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the fourth quarter, HoldingsChannel.com reports. The fund bought 839 shares of the healthcare conglomerate’s stock, valued at approximately $424,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in UNH. Means Investment CO. Inc. raised its holdings in shares of UnitedHealth Group by 5.7% in the fourth quarter. Means Investment CO. Inc. now owns 4,862 shares of the healthcare conglomerate’s stock valued at $2,459,000 after buying an additional 262 shares during the last quarter. Abner Herrman & Brock LLC grew its stake in shares of UnitedHealth Group by 3.1% during the fourth quarter. Abner Herrman & Brock LLC now owns 24,412 shares of the healthcare conglomerate’s stock worth $12,349,000 after purchasing an additional 737 shares during the period. Magnolia Capital Advisors LLC boosted its holdings in UnitedHealth Group by 110.2% during the fourth quarter. Magnolia Capital Advisors LLC now owns 3,806 shares of the healthcare conglomerate’s stock worth $1,925,000 after buying an additional 1,995 shares during the last quarter. Lynch Asset Management Inc. boosted its stake in UnitedHealth Group by 0.4% during the 4th quarter. Lynch Asset Management Inc. now owns 11,450 shares of the healthcare conglomerate’s stock worth $5,792,000 after acquiring an additional 50 shares during the last quarter. Finally, HHM Wealth Advisors LLC raised its holdings in UnitedHealth Group by 176.9% in the fourth quarter. HHM Wealth Advisors LLC now owns 2,921 shares of the healthcare conglomerate’s stock worth $1,477,000 after purchasing an additional 1,866 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

NYSE UNH opened at $542.30 on Monday. The company has a market capitalization of $499.07 billion, a price-to-earnings ratio of 34.99, a PEG ratio of 1.48 and a beta of 0.61. The stock has a fifty day simple moving average of $536.17 and a 200 day simple moving average of $565.26. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the previous year, the company earned $5.83 EPS. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.63 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.55%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on UNH shares. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Truist Financial decreased their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Stephens upped their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Finally, UBS Group dropped their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.